SCHEMBL4046112

SCHEMBL4046112

CC(C)(C)CCNC(=O)c1ccncc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLYCD O95822 1/20 0.62
NAAA Q02083 1/20 0.59
RAB9A P51151 2/20 0.55
CYP1A2 P05177 2/20 0.54
CYP2C19 P33261 2/20 0.54
CYP2C9 P11712 1/20 0.54
TSHR P16473 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.53
NPC1 O15118 1/20 0.53
MAPT P10636 1/20 0.53
EPHX2 P34913 1/20 0.53
KDM4E B2RXH2 1/20 0.52
MPO P05164 1/20 0.52
CYP3A4 P08684 1/20 0.52
ADORA3 P0DMS8 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2A6 P11509 1/20 0.52
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13508333 0.90 NAAA (0.65) MLYCDNAAARAB9ACYP1A2CYP2C19
SCHEMBL17865780 0.87 MLYCD (0.77) MLYCDRAB9AL3MBTL1SMN1; SMN2NPC1
SCHEMBL18457554 0.85 NAAA (0.55) MLYCDNAAARAB9ACYP1A2CYP2C19
SCHEMBL9339173 0.83 MAPT (0.69) NAAARAB9ACYP1A2CYP2C19CYP2C9
SCHEMBL8068299 0.82 ADORA2A (0.56) NAAARAB9ACYP1A2CYP2C19CYP2C9
SCHEMBL10224050 0.82 MLYCD (0.66) MLYCDNAAARAB9ASMN1; SMN2NPC1
SCHEMBL12243059 0.81 MLYCD (0.69) MLYCDRAB9AL3MBTL1SMN1; SMN2NPC1
SCHEMBL5687748 0.81 MLYCD (0.69) MLYCDRAB9ACYP1A2CYP2C19L3MBTL1
SCHEMBL6359135 0.80 NAAA (0.75) NAAARAB9ACYP1A2CYP2C19CYP2C9
SCHEMBL7213166 0.79 MLYCD (0.71) MLYCDRAB9AL3MBTL1NPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7531545-B2 2-amino-3,4-dihydro-pyrido[3,4-d]pyrimidine derivatives useful as inhibitors of β-secretase (BACE) JANSSEN PHARMACEUTICA, N.V. (BE) 2009-05-12 US disclosed
US-20070259898-A1 NOVEL 2-AMINO-3,4-DIHYDRO-PYRIDO[3,4-D]PYRIMIDINE DERIVATIVES USEFUL AS INHIBITORS OF beta-SECRETASE (BACE) BAXTER ELLEN E 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259898-A1 NOVEL 2-AMINO-3,4-DIHYDRO-PYRIDO[3,4-D]PYRIMIDINE DERIVATIVES USEFUL AS INHIBITORS OF beta-SECRETASE (BACE) BACE2, PSEN2, BACE1 MLYCD 2720/4885NAAA 480/4885RAB9A 2904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.